---
title: "Sanofi Down Over 5%, On Track for Largest Percent Decrease Since October 2023 — Data Talk"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/242625974.md"
description: "Sanofi SA Sponsored ADR (SNY) is down 5.2% to $49.63, marking its largest percent decrease since October 2023. The stock is on track for its lowest close since May 2025 and has declined 9.68% month-to-date. Year-to-date, it is up 2.9% but down 16.48% from its all-time high of $59.42 in March 2025. The stock traded as low as $48.58 today, with a significant intraday drop of 7.19%."
datetime: "2025-05-30T15:26:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242625974.md)
  - [en](https://longbridge.com/en/news/242625974.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242625974.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/242625974.md) | [English](https://longbridge.com/en/news/242625974.md)


# Sanofi Down Over 5%, On Track for Largest Percent Decrease Since October 2023 — Data Talk

Sanofi SA Sponsored ADR (SNY) is currently at $49.63, down $2.72 or 5.2%

\--Would be lowest close since May 14, 2025, when it closed at $49.21

\--On pace for largest percent decrease since Oct. 27, 2023, when it fell 19.13%

\--Currently down four of the past six days

\--Down 9.68% month-to-date; on pace for worst month since Oct. 2023, when it fell 15.64%

\--Up 2.9% year-to-date

\--Down 16.48% from its all-time closing high of $59.42 on March 6, 2025

\--Up 1.22% from 52 weeks ago (May 31, 2024), when it closed at $49.03

\--Down 16.48% from its 52-week closing high of $59.42 on March 6, 2025

\--Up 8.15% from its 52-week closing low of $45.89 on Dec. 16, 2024

\--Traded as low as $48.58; lowest intraday level since April 9, 2025, when it hit $47.70

\--Down 7.19% at today's intraday low; largest intraday percent decrease since Oct. 27, 2023, when it fell as much as 20.06%

All data as of 10:58:52 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

May 30, 2025 11:16 ET (15:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

### 相關股票

- [Sanofi (SNYNF.US)](https://longbridge.com/zh-HK/quote/SNYNF.US.md)

## 相關資訊與研究

- [Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval](https://longbridge.com/zh-HK/news/280786871.md)
- [Sanofi Secures EU Conditional Marketing Approval for Graft-vs-Host Disease Medicine](https://longbridge.com/zh-HK/news/281129645.md)
- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-HK/news/281323250.md)
- [Norfolk Southern Earnings Preview: What to Expect](https://longbridge.com/zh-HK/news/280999046.md)
- [Philip Morris International Presents its Value Report 2025: change in motion | PM Stock News](https://longbridge.com/zh-HK/news/281150794.md)